<?xml version="1.0" encoding="UTF-8"?>
<ref id="B76-vaccines-07-00203">
 <label>76.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Modhiran</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Watterson</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Muller</surname>
    <given-names>D.A.</given-names>
   </name>
   <name>
    <surname>Panetta</surname>
    <given-names>A.K.</given-names>
   </name>
   <name>
    <surname>Sester</surname>
    <given-names>D.P.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Hume</surname>
    <given-names>D.A.</given-names>
   </name>
   <name>
    <surname>Stacey</surname>
    <given-names>K.J.</given-names>
   </name>
   <name>
    <surname>Young</surname>
    <given-names>P.R.</given-names>
   </name>
  </person-group>
  <article-title>Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity</article-title>
  <source>Sci. Transl. Med.</source>
  <year>2015</year>
  <volume>7</volume>
  <fpage>304ra142</fpage>
  <pub-id pub-id-type="doi">10.1126/scitranslmed.aaa3863</pub-id>
 </element-citation>
</ref>
